Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Sabine Blum,
Yves Chalandon,
Myriam Labopin,
Jürgen Finke,
Tobias Gedde-Dahl,
Tarek Ben Othman,
Jan J. Cornelissen,
Pavel Jindra,
Hélène Labussière-Wallet,
Matthew Collin,
Stig Lenhoff,
Guido Kobbe,
Norma C. Gutiérrez,
Arnon Nagler,
Mohamad Mohty
Affiliations
Sabine Blum
Hematology Service, University Hospital and University of Lausanne, Lausanne
Yves Chalandon
Division of Hematology and Faculty of Medicine, Geneva University Hospitals and University of Geneva, Geneva
Myriam Labopin
Sorbonne University, Department of Hematology, EBMT Paris study office, Hôpital Saint Antoine, and INSERM UMRs 938, Paris
Jürgen Finke
University Hospital of Freiburg, Freiburg
Tobias Gedde-Dahl
University Hospital Oslo, Oslo
Tarek Ben Othman
Centre National de Greffe de Moelle, Tunis, Tunisia
Jan J. Cornelissen
Erasmus MC Cancer Institute, University Rotterdam
Pavel Jindra
Charles University Hospital, Pilsen, Czech Republic
Hélène Labussière-Wallet
Hôpital Lyon Sud, Pierre Bénite
Matthew Collin
Freeman Hospital, Newcastle_Upon Tyne
Stig Lenhoff
Skanes University Hospital, Lund, Sweden
Guido Kobbe
University Hospital Duesseldorf, Heinrich Heine University, Medical Faculty, Duesseldorf
Norma C. Gutiérrez
University Hospital of Salamanca, IBSAL, Cancer Research Center-IBMCC (USALCSIC), CIBERONC (CB16/12/00233), Salamanca, Spain
Arnon Nagler
Chaim Sheba Medical Center, Tel-Hashomer, Israel
Mohamad Mohty
Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris
